ArQule to present tivantinib clinical trial data at ASCO 2014

[News]

ArQule, Inc. today announced that tivantinib will be included in seven presentations during the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held from May 30, 2014 to June 3, 2014 in Chicago, Illinois.

More... (http://www.news-medical.net/news/20140531/ArQule-to-present-tivantinib-clinical-trial-data-at-ASCO-2014.aspx)